tiziana-logo.png
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
17. Dezember 2024 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Cayosoft Logo.png
Cayosoft Guardian Forest Recovery Wins InfoWorld’s 2024 Technology of the Year Award
12. Dezember 2024 12:00 ET | Cayosoft
COLUMBUS, Ohio, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., a leader in Microsoft management and security, today announced that Cayosoft Guardian Forest Recovery™ has been named the winner in...
Cayosoft Logo.png
Cayosoft joins the Microsoft Intelligent Security Association
19. November 2024 13:30 ET | Cayosoft
COLUMBUS, Ohio, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., a leader in Microsoft management and security, today announced it has become a member of the Microsoft Intelligent Security...
Cayosoft Logo.png
Cayosoft Wins Patent for Revolutionary Instant Active Directory Recovery Solution
24. September 2024 09:00 ET | Cayosoft
COLUMBUS, Ohio, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., the leader in Microsoft Active Directory management, monitoring, and recovery, has secured the patent for its flagship product,...
The Highly Anticipat
The Highly Anticipated FDA Approvals of Galderma’s Nemolizumab and Eli Lilly’s Lebrikizumab are Expected to Shift Dermatologists’ Perceptions of the Atopic Dermatitis Market
09. September 2024 10:20 ET | Spherix Global Insights
EXTON, PA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Since its 2017 debut as the first advanced systemic treatment for atopic dermatitis (AD), Sanofi/Regeneron’s Dupixent has dominated the US market....
Ivor HS
Tiziana Life Sciences Appoints New Chief Executive Officer
19. August 2024 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Cayosoft Logo.png
Cayosoft Releases Microsoft Threat Detection for Recently Discovered VMware ESXi Authentication Bypass Vulnerability
07. August 2024 09:00 ET | Cayosoft
COLUMBUS, Ohio, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., the leader in hybrid Microsoft Active Directory management, monitoring and recovery, today announced that its Active Directory threat...
Tatari Logo.jpg
Tatari Unveils Fully AI-Powered Media Buying Across Linear and Streaming TV
17. Juli 2024 09:52 ET | Tatari Inc.
SAN FRANCISCO, July 17, 2024 (GLOBE NEWSWIRE) -- Tatari, a leading platform for buying and measuring advertising across convergent TV (linear, streaming and online video) introduced its AI-Enabled...
ANVS logo.jpg
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
16. Juli 2024 08:00 ET | Annovis Bio, Inc.
MALVERN, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
tiziana-logo.png
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
26. Juni 2024 07:00 ET | Tiziana Life Sciences Ltd.
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab